News

Friday
May, 24

BCCI asks Virat Kohli, others not to make ‘confidential matter’ public | Cricket News

Featured in:


NEW DELHI: After Virat Kohli shared his Yo-Yo test score on social media platform Instagram on Thursday, the Indian cricket board was reportedly unhappy and communicated to the former captain and other players not to put confidential information in public domain.
The players are currently undergoing a six-day preparatory camp at Alur, Bengaluru ahead of the start of Asia Cup.
Kohli after his Yo-Yo test in the camp had put out on social media that he scored 17.2 in the fitness test.

It is learnt that the players after the incident were ‘verbally’ advised about the BCCI‘s view.
Citing that the display of fitness scores on social media amounts to breach of contract clause, the Indian team management, soon after the incident, gave the players a reminder to avoid putting their fitness scores in the public domain.
“Players have been informed verbally to avoid posting any confidential matter on social media platforms. They can post pictures while training but posting a score leads to breach of contract clause,” The Indian Express quoted a BCCI source as saying.
Virat, who scored 17.2 in the test was well above the reported acceptable mark of 16.5.

AI cricket





Source link

Find us on

Latest articles

- Advertisement - spot_imgspot_img

Related articles

Adani Enterprises shares in news today as firm to...

Adani Enterprises shares in news today as firm to consider raising of funds Adani Enterprises stock closed 8.01%...

PHD Marketing Takes Top Team to Drupa 2024

PHD Marketing Takes Top Team to Drupa 2024 Leading 360-degree B2B agency PHD Marketing is descending upon Düsseldorf...

Terinex Flexibles Opens Net Zero Co2 Rated Factory Building

Terinex Flexibles Opens Net Zero Co2 Rated Factory Building Terinex Flexibles is pleased to announce the opening of...

Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts...

Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers “As the widespread adoption of...

Celltrion receives European Commission approval of Omlyclo (CT-P39), the...

Celltrion receives European Commission approval of Omlyclo (CT-P39), the first and only omalizumab biosimilar approved in Europe The...

Publication of Definitive Interim Result of the Public Tender...

Publication of Definitive Interim Result of the Public Tender Offer – Constantia Holds 86.38% and Declares the...